Latest Insider Transactions at Hims & Hers Health, Inc. (HIMS)
This section provides a real-time view of insider transactions for Hims & Hers Health, Inc. (HIMS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Hims & Hers Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Hims & Hers Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 12
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
1,954,379
+39.42%
|
-
|
|
Nov 12
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Bona fide gift
|
Indirect |
1,954,379
-100.0%
|
-
|
|
Nov 10
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
1,049,692
+50.0%
|
-
|
|
Nov 10
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Bona fide gift
|
Indirect |
1,049,692
-100.0%
|
-
|
|
Nov 10
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Other acquisition or disposition
|
Indirect |
260,000
-99.08%
|
-
|
|
Nov 10
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,637
-1.66%
|
$110,754
$42.53 P/Share
|
|
Nov 07
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
262,423
+50.0%
|
-
|
|
Nov 07
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Bona fide gift
|
Indirect |
262,423
-100.0%
|
-
|
|
Oct 27
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,637
-1.64%
|
$131,850
$50.1 P/Share
|
|
Oct 17
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,592
-14.17%
|
$660,744
$57.13 P/Share
|
|
Oct 17
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,592
+6.76%
|
$92,736
$8.27 P/Share
|
|
Oct 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
128,127
-12.58%
|
$7,943,874
$62.9 P/Share
|
|
Oct 16
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125,335
+24.24%
|
$250,670
$2.43 P/Share
|
|
Oct 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
47,534
-28.1%
|
$2,994,642
$63.08 P/Share
|
|
Oct 13
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,637
-1.61%
|
$142,398
$54.38 P/Share
|
|
Oct 10
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
900
-0.31%
|
$52,200
$58.25 P/Share
|
|
Oct 10
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
900
+0.31%
|
$5,400
$6.82 P/Share
|
|
Oct 03
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
11,595
-14.17%
|
$660,915
$57.72 P/Share
|
|
Oct 03
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,595
+6.76%
|
$92,760
$8.27 P/Share
|
|
Oct 01
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
250
-0.09%
|
$14,000
$56.0 P/Share
|
|
Oct 01
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+0.09%
|
$2,750
$11.53 P/Share
|
|
Sep 29
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,637
-1.58%
|
$152,946
$58.79 P/Share
|
|
Sep 29
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
85,000
-54.76%
|
$5,100,000
$60.2 P/Share
|
|
Sep 29
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
49,832
+24.3%
|
$249,160
$5.01 P/Share
|
|
Sep 24
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,100
-0.72%
|
$117,600
$56.52 P/Share
|
|
Sep 24
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,100
+0.71%
|
$10,500
$5.01 P/Share
|
|
Sep 22
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
23,584
-18.28%
|
$1,344,288
$57.74 P/Share
|
|
Sep 17
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
65,110
-40.59%
|
$3,255,500
$50.57 P/Share
|
|
Sep 17
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
13,749
-4.42%
|
$687,450
$50.5 P/Share
|
|
Sep 17
2025
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
8,410
-85.57%
|
$420,500
$50.5 P/Share
|
|
Sep 17
2025
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,021
-5.57%
|
$501,050
$50.5 P/Share
|
|
Sep 17
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,637
-1.56%
|
$131,850
$50.5 P/Share
|
|
Sep 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
128,127
-8.58%
|
$6,790,731
$53.65 P/Share
|
|
Sep 16
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125,335
+18.74%
|
$250,670
$2.43 P/Share
|
|
Sep 16
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
47,534
-18.33%
|
$2,519,302
$53.38 P/Share
|
|
Sep 15
2025
|
Andrew Dudum Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
90,672
-35.71%
|
$4,805,616
$53.96 P/Share
|
|
Sep 15
2025
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
164,368
+39.3%
|
-
|
|
Sep 15
2025
|
Michael Chi Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
39,872
-11.37%
|
$2,113,216
$53.96 P/Share
|
|
Sep 15
2025
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
76,256
+4.63%
|
$533,792
$7.79 P/Share
|
|
Sep 15
2025
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,150
-1.47%
|
$232,400
$56.0 P/Share
|
|
Sep 15
2025
|
Irene Becklund PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,867
-47.43%
|
$469,951
$53.96 P/Share
|
|
Sep 15
2025
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,983
+49.03%
|
-
|
|
Sep 15
2025
|
Soleil Boughton Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
22,829
-11.9%
|
$1,209,937
$53.96 P/Share
|
|
Sep 15
2025
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,420
+17.75%
|
-
|
|
Sep 15
2025
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,500
-3.49%
|
$344,500
$53.96 P/Share
|
|
Sep 15
2025
|
Patrick Harrison Carroll Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,521
+8.14%
|
-
|
|
Sep 15
2025
|
Kare Schultz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
6,623
+29.61%
|
-
|
|
Sep 15
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
145,000
-30.21%
|
$7,975,000
$55.52 P/Share
|
|
Sep 15
2025
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
215,199
+30.4%
|
$1,075,995
$5.01 P/Share
|
|
Sep 15
2025
|
Oluyemi Okupe Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
58,021
-26.14%
|
$3,075,113
$53.96 P/Share
|